Literature DB >> 16273647

Serum leptin levels and insulin resistance are associated with gallstone disease in overweight subjects.

Nahum Méndez-Sánchez1, Luisa-B Bermejo-Martínez, Yolanda Viñals, Norberto-C Chavez-Tapia, Irina Vander Graff, Guadalupe Ponciano-Rodríguez, Martha-H Ramos, Misael Uribe.   

Abstract

AIM: To establish an association between the serum leptin levels and the development of gallstone disease (GD).
METHODS: We carried out a non-matched case-controlled study in a university hospital in Mexico City. Two hundred and eighty-seven subjects were included: 97 cases with gallstones and 190 controls. Body mass index (BMI), fasting plasma leptin, insulin, serum lipid, and lipoprotein levels were measured. Insulin resistance was calculated by homeostasis model assessment (HOMA-IR). Unconditional logistic regression analysis (univariate and multivariate) stratified by BMI was used to calculate the risk of GD.
RESULTS: The multivariate conditional regression analysis revealed a model for those patients with BMI <30. The selected variables in the model were HOMA-IR index with OR = 1.31, P = 0.02 and leptin higher than median with OR = 2.11, P = 0.05. In the stratum of BMI >=30, we did not find a useful model.
CONCLUSION: We concluded that insulin resistance and the development of GD appears to be associated with serum leptin levels in subjects with overweight, but not in obese subjects with similar metabolic profiles.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16273647      PMCID: PMC4436637          DOI: 10.3748/wjg.v11.i39.6182

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  41 in total

1.  Serum leptin and lipid profiles in Thai obese and overweight subjects.

Authors:  R Tungtrongchitr; P Pongpaew; B Phonrat; S Tribunyatkul; D Viroonudomphol; V Supawan; P Jintaridhi; A Lertchavanakul; N Vudhivai; F P Schelp
Journal:  Int J Vitam Nutr Res       Date:  2001-01       Impact factor: 1.784

2.  Impaired biliary lipid secretion in obese Zucker rats: leptin promotes hepatic cholesterol clearance.

Authors:  S VanPatten; N Ranginani; S Shefer; L B Nguyen; L Rossetti; D E Cohen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-08       Impact factor: 4.052

3.  Leptin and HDL-cholesterol in non-diabetic normotensive subjects.

Authors:  G M Marinari; N Scopinaro; G F Adami
Journal:  Obes Surg       Date:  2001-06       Impact factor: 4.129

4.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

5.  Plasma insulin, serum lipids and lipoproteins in gall stone disease in non-insulin dependent diabetic subjects: a case control study.

Authors:  M Laakso; M Suhonen; R Julkunen; K Pyörälä
Journal:  Gut       Date:  1990-03       Impact factor: 23.059

6.  Gallbladder motility in agouti-yellow and leptin-resistant obese mice.

Authors:  Khoi Q Tran; Deborah A Swartz-Basile; Attila Nakeeb; Henry A Pitt
Journal:  J Surg Res       Date:  2003-07       Impact factor: 2.192

7.  Leptin promotes biliary cholesterol elimination during weight loss in ob/ob mice by regulating the enterohepatic circulation of bile salts.

Authors:  Hideyuki Hyogo; Suheeta Roy; Beverly Paigen; David E Cohen
Journal:  J Biol Chem       Date:  2002-07-11       Impact factor: 5.157

8.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans.

Authors:  R V Considine; M K Sinha; M L Heiman; A Kriauciunas; T W Stephens; M R Nyce; J P Ohannesian; C C Marco; L J McKee; T L Bauer
Journal:  N Engl J Med       Date:  1996-02-01       Impact factor: 91.245

Review 9.  Non-HDL cholesterol as a measure of atherosclerotic risk.

Authors:  Chris J Packard; Yasushi Saito
Journal:  J Atheroscler Thromb       Date:  2004       Impact factor: 4.928

Review 10.  Regulation of reverse cholesterol transport and clinical implications.

Authors:  Daniel J Rader
Journal:  Am J Cardiol       Date:  2003-08-18       Impact factor: 2.778

View more
  5 in total

1.  Routine liver biopsy to screen for nonalcoholic fatty liver disease (NAFLD) during cholecystectomy for gallstone disease: is it justified?

Authors:  Antonio Ramos-De la Medina; José M Remes-Troche; Federico B Roesch-Dietlen; Alfonso G Pérez-Morales; Silvia Martinez; Silvia Cid-Juarez
Journal:  J Gastrointest Surg       Date:  2008-09-30       Impact factor: 3.452

2.  Effect of diabetes mellitus on survival in patients with gallbladder Cancer: a systematic review and meta-analysis.

Authors:  Chen Jing; Zhengyi Wang; Xue Fu
Journal:  BMC Cancer       Date:  2020-07-24       Impact factor: 4.430

3.  Insights into modifiable risk factors of cholelithiasis: A Mendelian randomization study.

Authors:  Lanlan Chen; Hongqun Yang; Haitao Li; Chang He; Liu Yang; Guoyue Lv
Journal:  Hepatology       Date:  2021-12-13       Impact factor: 17.298

Review 4.  Gastrointestinal and Liver Complications in Patients with Diabetes Mellitus-A Review of the Literature.

Authors:  Ruxandra Mare; Ioan Sporea
Journal:  J Clin Med       Date:  2022-09-04       Impact factor: 4.964

5.  Epidemiology of gallbladder disease: cholelithiasis and cancer.

Authors:  Laura M Stinton; Eldon A Shaffer
Journal:  Gut Liver       Date:  2012-04-17       Impact factor: 4.519

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.